A recent report showed that VEGFB promoted trans-endothelial delivery of LCFAs to tumor cells through mTORC1 signaling, and loss of endothelial mTORC1 reduced LCFA in tumor cells and T cell in lung metastatic TME, leading to metastasis inhibition [65]. Here, VEGFB is linked to neoplasm.